Skip to Main Content

Paper Details

The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes.
Diabetes, Obesity and Metabolism
60
2020
Author NameAffiliation
Marja-Riitta TaskinenResearch Program for Clinical and Molecular Medicine Unit, University of Helsinki
  • 1 - 1

Datasets

Release 1.2